At its core, l’affaire EpiPen is not about a single drug maker making sky’s-the-limit profits. It’s about how we pay for pharmaceuticals, how we contain price increases, and ultimately, who gets to use the drugs.
Healthcare Systems & Policy
A reporter explores what Obamacare has meant for the health of DACA recipients and their undocumented family members. For many such families, reform has result in a patchwork quilt of eligibility.
While California's Medicaid expansion has helped provide first-time health insurance to residents throughout the Central San Joaquin Valley, patients living in rural communities still face tremendous obstacles to actually receiving care.
Doctors see patients with cases of food poisoning all the time. But patients too rarely bother to report the incidents to their local health department. If they did, we'd all be happier diners.
The Federal Trade Commission and California Attorney General have spent more than three years examining the merger proposal to weigh antitrust concerns.
Breastfeeding rates have risen in recent years, but big differences remain between states. Here's a look at the latest numbers and why many moms still find it hard to breastfeed.
Here we check in with prominent health journalists and experts to see what sites, newsletters and social media feeds they turn to first every morning. This week, we caught up with Charles Ornstein, senior reporter for ProPublica.
As the legalization of weed appears imminent in California, former Los Angeles Times reporter Sam Quinones says the crucial question we should be asking is, "What kind of marijuana should we legalize?"
Our health care system commits tremendous resources to extending life but comparatively little to end-of-life planning and care that honors patients’ wishes. As a result, many people find themselves subjected to unnecessary treatments and spend their final moments in hospitals rather than at home.
"It's our obligation to offer treatment in a manner that's rational and logical," said the county's chief medical officer. "We identify the individuals for initial treatment right now, based on how we can offer the most care to the most people, who are going to benefit from it the most now."